Published on
06:35 GMT
Rare Disease Leaders Call for Regulatory Consistency After Chaotic Year
Rare diseases should be enjoying a moment at Marty Makary’s FDA. The FDA commissioner, along with Center for Biologics Evaluation and Research director Vinay Prasad, has made numerous statements throughout the year apparently supportive of easing market …
Source:
BioSpace
-
Pending
